CAP2

CAP2
204901032013

Number of Participants

1500

Eligibility

Participants must have non-valvular atrial fibrillation (AF) that requires prophylaxis for potential thrombus formation. A transthoracic and a transesophageal echocardiogram must be completed prior to enrollment to confirm eligibility criteria.

Purpose

The purpose of this study is to provide access to an investigational device used to help prevent blood clot formation in the heart.

Treatment

If determined that you are eligible, a left atrial appendage closure device will be implanted into your heart

Principal Investigator

John J. Lopez

M.D., FACC, FSCAI
Cardiology
Professor

Enrollment

(708) 216-2644

More Clinical Trials

See Also

© 2011 Loyola University Chicago Health Sciences Division. All rights reserved.  &npsp; Privacy Policy   Privacy Policy